Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 16 studies | 23% ± 7% | |
capillary endothelial cell | 9 studies | 20% ± 4% | |
endothelial cell of vascular tree | 7 studies | 21% ± 6% | |
endothelial cell of lymphatic vessel | 6 studies | 23% ± 7% | |
vein endothelial cell | 5 studies | 22% ± 5% | |
endothelial cell of artery | 4 studies | 20% ± 3% | |
glomerular endothelial cell | 3 studies | 17% ± 0% | |
epithelial cell | 3 studies | 31% ± 7% |
Insufficient scRNA-seq data for expression of TNFAIP1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 4432.76 | 1445 / 1445 | 100% | 83.98 | 183 / 183 |
lung | 100% | 7028.64 | 578 / 578 | 100% | 66.84 | 1155 / 1155 |
stomach | 100% | 3492.14 | 359 / 359 | 100% | 55.07 | 286 / 286 |
breast | 100% | 5410.23 | 459 / 459 | 100% | 66.88 | 1114 / 1118 |
brain | 100% | 3333.68 | 2639 / 2642 | 100% | 71.27 | 703 / 705 |
ovary | 100% | 2843.47 | 180 / 180 | 100% | 39.72 | 428 / 430 |
skin | 100% | 4538.97 | 1809 / 1809 | 99% | 50.62 | 469 / 472 |
uterus | 100% | 3579.29 | 170 / 170 | 99% | 65.05 | 456 / 459 |
intestine | 100% | 3344.39 | 966 / 966 | 99% | 51.52 | 523 / 527 |
bladder | 100% | 3698.90 | 21 / 21 | 99% | 57.10 | 499 / 504 |
kidney | 100% | 5019.39 | 89 / 89 | 99% | 67.16 | 891 / 901 |
pancreas | 100% | 3698.88 | 328 / 328 | 99% | 53.69 | 176 / 178 |
thymus | 100% | 4425.18 | 653 / 653 | 98% | 47.71 | 594 / 605 |
prostate | 100% | 3772.18 | 245 / 245 | 98% | 37.40 | 491 / 502 |
liver | 100% | 5091.20 | 226 / 226 | 98% | 45.10 | 397 / 406 |
adrenal gland | 100% | 5067.01 | 258 / 258 | 92% | 31.27 | 212 / 230 |
adipose | 100% | 5495.19 | 1204 / 1204 | 0% | 0 | 0 / 0 |
spleen | 100% | 8662.82 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 73.81 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 21.35 | 1 / 1 |
heart | 100% | 4079.26 | 860 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 3319.25 | 1333 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 2377.88 | 801 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 98% | 33.08 | 78 / 80 |
lymph node | 0% | 0 | 0 / 0 | 86% | 20.38 | 25 / 29 |
peripheral blood | 60% | 870.41 | 559 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0035024 | Biological process | negative regulation of Rho protein signal transduction |
GO_0051260 | Biological process | protein homooligomerization |
GO_0016567 | Biological process | protein ubiquitination |
GO_0006955 | Biological process | immune response |
GO_0045740 | Biological process | positive regulation of DNA replication |
GO_0006915 | Biological process | apoptotic process |
GO_0043149 | Biological process | stress fiber assembly |
GO_0016477 | Biological process | cell migration |
GO_0043161 | Biological process | proteasome-mediated ubiquitin-dependent protein catabolic process |
GO_0031463 | Cellular component | Cul3-RING ubiquitin ligase complex |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0005768 | Cellular component | endosome |
GO_0005634 | Cellular component | nucleus |
GO_0042802 | Molecular function | identical protein binding |
GO_0031267 | Molecular function | small GTPase binding |
GO_0004842 | Molecular function | ubiquitin-protein transferase activity |
GO_0005515 | Molecular function | protein binding |
GO_0030332 | Molecular function | cyclin binding |
Gene name | TNFAIP1 |
Protein name | BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 2 (BTB/POZ domain-containing protein TNFAIP1) BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 2 (hBACURD2) (BTB/POZ domain-containing protein TNFAIP1) (Protein B12) (Tumor necrosis factor, alpha-induced protein 1, endothelial) TNF alpha induced protein 1 |
Synonyms | EDP1 BACURD2 |
Description | FUNCTION: Substrate-specific adapter of a BCR (BTB-CUL3-RBX1) E3 ubiquitin-protein ligase complex involved in regulation of cytoskeleton structure. The BCR(TNFAIP1) E3 ubiquitin ligase complex mediates the ubiquitination of RHOA, leading to its degradation by the proteasome, thereby regulating the actin cytoskeleton and cell migration. Its interaction with RHOB may regulate apoptosis. May enhance the PCNA-dependent DNA polymerase delta activity. . |
Accessions | ENST00000544907.6 [Q13829-2] ENST00000582302.2 ENST00000226225.7 [Q13829-1] J3QSD4 Q13829 ENST00000578158.5 K7EM01 ENST00000577535.1 J3QS43 |